本公司合作信息
- 創(chuàng)新開(kāi)發(fā)新藥，可為千百萬(wàn)患者減輕疾苦。效果顯著效益好。
- 開(kāi)發(fā)新藥為全球千百萬(wàn)患者減輕疾苦。
- 歡迎合作開(kāi)發(fā)新藥，省時(shí)省錢(qián)效果好。
- 開(kāi)發(fā)新藥尋求合作者
- 省下10年時(shí)間10億美元，合作開(kāi)發(fā)新藥為千百萬(wàn)人減輕疾苦。
- 創(chuàng)新合作開(kāi)發(fā)新藥。
- 創(chuàng)新合作開(kāi)發(fā)新藥。
- 創(chuàng)新合作開(kāi)發(fā)新藥。
- 合作開(kāi)發(fā)新藥。
- 省下10年時(shí)間10億美元，開(kāi)發(fā)新藥可為千百萬(wàn)患者減輕疾苦。
熱門(mén)資訊推薦
- ·聚焦打造具有全球競(jìng)爭(zhēng)力的生物醫(yī)藥產(chǎn)業(yè)，9個(gè)重大項(xiàng)目簽約
- ·復(fù)星醫(yī)藥與梯瓦達(dá)成戰(zhàn)略合作
- ·中非醫(yī)藥合作邁入新階段 21家中國(guó)藥企加入西非醫(yī)療供應(yīng)鏈平臺(tái)
- ·江蘇4項(xiàng)目入選智慧健康養(yǎng)老推廣目錄
- ·三星醫(yī)療預(yù)中標(biāo)約2.13億元國(guó)家電網(wǎng)采購(gòu)項(xiàng)目
- ·國(guó)家醫(yī)保局解讀醫(yī)療服務(wù)價(jià)格立項(xiàng)指南，四類(lèi)項(xiàng)目?jī)r(jià)格調(diào)整落地
- ·邁克生物多個(gè)項(xiàng)目入選四川省創(chuàng)新醫(yī)療器械融合應(yīng)用試點(diǎn)
- ·中關(guān)村醫(yī)療器械成果轉(zhuǎn)化平臺(tái)已儲(chǔ)備200余個(gè)項(xiàng)目
- ·瀘州今年重點(diǎn)實(shí)施57個(gè)醫(yī)藥健康產(chǎn)業(yè)項(xiàng)目
- ·睿智醫(yī)藥：“中國(guó)-馬來(lái)西亞生物醫(yī)藥產(chǎn)業(yè)園”框架合作協(xié)議成功簽署
COOPERATION
發(fā)布時(shí)間：2008/7/8 11:06:00 瀏覽次數(shù)：427 類(lèi)別：其它詳情介紹
-
More effective and better foreground-The research and development of a new drug which can replace cardiac pacemaker
Currently, there is not effective drugs which can cure bradycardia, patient with severe symptoms have to use the cardiac pacemaker to sustain life. More than 600 thousand patients will be equipped with cardiac pacemakers each year. Millions of patients are expecting a new drug will can cure this disease and help them get rid of cardiac pacemakers.
To install a cardiac pacemaker not only means a large sum of money , but also the affliction and risks from the clinical operation. What's more, a lot of side effects and restrictions exist and the patient will replace with a new one in a few years. So, it is very urgent to research on some effective new drugs which are effective to patients with bradycardia.
We are physicians chief. Through 27 years in clinical search, we achieved significant therapeutic effects in curing bradycardia (mainly including sick sinus syndrome and third degree Atrio-Ventricular block) with Xindekuai.. Only after oral taking of this medicine for three days, improvement of heart rate, increase in cardiac outputs and improvement of cardiac function can be seen. These make the symptoms decrease or even disappear which enable the patients to survive without cardiac pacemakers. Widely use of the new medicine will alleviate millions of patients who suffer from the disease and also can be taken as a key project in economic exchange with foreign countries.
Xindekuai Prescription has been tested in Pharmacodynamic experiments and toxicological experiments using animal models, which have proven effectiveness.
Xindekuai Prescription has been evaluated by experts appointed by the Chamber of Scinece and Technology of Anhui Province, which has been passed.
Xindekuai Prescription win the 16th Shanghai Execllent-Invention Prize.
Xindekuai Prescription has not acquired the new drug certification up to now, we are eager to cooperate with people with wisdom and ability to develop this promising new drug. There are three advantages in developing this drug:
1. No risk : this new Prescription has been searched clinically for 27 years with excellent therapeutic effects and low adverse effests and low adverse effects. And the tests in animal models also indicate its effectiveness.
2. Low investment, short cycle: because the old drugs have been discovered, which have new use with reasonable and simple prescription.
3. well prospect: millions upon millions of patients are waiting anxi ously for the new drug to come to marker. Welcome to cooperate in developing this promising new drug.
Note: Xindekuai is a kind of compound tablet or capsule,chemical matter has been determined.
Liaison man: Doctor Lin.
聯(lián)系方式
-
聯(lián) 系 人： 林青
聯(lián)系地址： 蚌埠醫(yī)學(xué)院二附院
電 話(huà)： 0571-85885083
